CHICAGO, July 29,
2024 /PRNewswire/ -- The global Prefilled
Syringes Market is expected to grow from USD
7.1 billion in 2024 to USD 13.1
billion by 2030, at a CAGR of 10.8%. Prefilled syringes are
a convenient and precise medical device for delivering single doses
of medication, reducing drug waste and extending product lifespan.
They are increasingly adopted due to rising chronic illnesses,
demand for effective drug delivery, and regulatory support for
safer injection methods. Commonly used for biologics, vaccines, and
other therapeutic products, these syringes enhance patient safety
by minimizing errors and improving dosing accuracy. The market is
expanding due to the prevalence of chronic diseases and the growing
trend towards self-administration. However, challenges such as
product recalls and competition from alternative drug delivery
methods may impact growth. The market is driven by rising demand
for biologics and biosimilars, with glass and single-chamber
syringes expected to dominate. North
America leads the market due to its advanced healthcare
infrastructure and high demand for precise drug delivery solutions.
Key players include BD, Gerresheimer AG, SCHOTT, and West
Pharmaceutical Services, among others.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331
Browse in-depth TOC on "Prefilled Syringes
Market"
243 - Tables
59 - Figures
292 -
Pages
BD (US): Leader in Medical Technology and Drug Delivery
Systems
BD stands out as a prominent player in medical technology,
specializing in the production and sale of medical devices,
reagents, and instruments. The company's diverse portfolio includes
syringes and pen needles, intravenous catheters, infusion pumps,
automated medication dispensing systems, pre-fillable drug delivery
systems, and respiratory equipment. BD operates through three main
segments: BD Medical, BD Life Sciences, and BD Interventional. The
BD Medical segment encompasses Medication Delivery Solutions,
Medication Management Solutions, and Pharmaceutical Systems. With
operations in over 190 countries and 70 manufacturing locations,
BD's extensive global reach and robust infrastructure support its
position as a leading innovator in the healthcare sector.
Gerresheimer AG (Germany):
Leader in Medicine Packaging and Drug Delivery Devices
Gerresheimer AG excels in medicine packaging and drug delivery
solutions, offering a comprehensive range of products for the
pharmaceutical, healthcare, biotechnology, and well-being sectors.
The company's operations are divided into three segments: Plastics
& Devices, Primary Packaging Glass, and Advanced Technologies.
Gerresheimer's global presence includes over 40 manufacturing
facilities across Europe,
North America, South America, and Asia. Notable subsidiaries include
Gerresheimer Querétaro S.A. (Mexico), Gerresheimer Glass Inc. (US), and
Kimble Chase (US). The company's
innovative approach to secure and efficient medication
administration reinforces its leadership in the industry.
Schott AG (Germany): Specialist in Specialty Glass
Materials and Drug Packaging
Schott AG, a subsidiary of Carl Zeiss Stiftung AG, is a
technology group known for its expertise in specialty glass
materials and glass-ceramics. The company's Pharma business unit,
within the Precision Materials segment, focuses on syringes, vials,
ampoules, and cartridges. Schott operates manufacturing sites and
sales offices in 33 countries, spanning Europe, Asia,
the Middle East, Africa, North
America, and South America.
The company's broad portfolio and global operational footprint
highlight its significant role in advancing drug packaging
solutions and specialty materials.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=16618331
Product Segmentation: Conventional Prefilled Syringes Lead
the Market
The prefilled syringe market is categorized into conventional
prefilled syringes and safety prefilled syringes. In 2023,
conventional prefilled syringes held the largest market share. This
dominance is attributed to their widespread use,
cost-effectiveness, and established reliability. Conventional
prefilled syringes, which are preloaded with medication, offer key
benefits including reduced medication errors, improved dosing
accuracy, and enhanced patient safety. Their convenience for
healthcare professionals and patients, coupled with the rising
prevalence of chronic diseases requiring regular injections,
further drives their market leadership. Additionally, innovations
in syringe materials and manufacturing technologies have enhanced
the safety and usability of conventional prefilled syringes.
Material Segmentation: Glass Prefilled Syringes
Dominate
The market for prefilled syringes is divided into glass
prefilled syringes and plastic prefilled syringes. In 2023, glass
prefilled syringes led the market due to their superior chemical
compatibility, which ensures drug stability and efficacy by
minimizing interactions with pharmaceutical drugs. Glass syringes'
excellent barrier properties prevent oxygen and moisture from
affecting the medication, preserving its integrity. Their robust
and inert nature makes them resistant to breakage and
contamination, offering enhanced safety and reliability. The
well-established manufacturing processes for glass syringes
contribute to their widespread adoption and consistent quality.
Design Segmentation: Single-Chamber Prefilled Syringes
Lead
The prefilled syringe market is segmented into single-chamber,
dual-chamber, and customized prefilled syringes. In 2023,
single-chamber prefilled syringes emerged as the dominant segment.
This is due to their ease of use, enhanced patient safety, and
reduced risk of medication errors. Single-chamber syringes, which
come preloaded with a precise dose of medication, minimize manual
preparation and decrease contamination risks. Their reliability and
convenience make them preferred for administering vaccines,
biologics, and emergency medications. The trend towards
self-administration and the demand for advanced drug delivery
systems further support the growing adoption of single-chamber
prefilled syringes.
Application Segmentation: Cancer Leads the Market
The prefilled syringe market is divided by application into
diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis,
ophthalmology, and others. In 2023, the cancer segment is projected
to hold the largest market share. This is driven by the increasing
global prevalence of cancer, which requires frequent and precise
administration of injectable medications. Prefilled syringes offer
significant advantages such as reducing dosage errors, minimizing
contamination, and enhancing patient safety, which are crucial in
oncology treatments. The growing use of biologics and biosimilars
in cancer therapy further boosts the demand for prefilled
syringes.
Regional Insights: North America Holds the Largest
Share
The global prefilled syringe market is segmented by region into
North America, Europe, Asia-Pacific, Latin
America, the Middle East,
and Africa. In 2023, North America accounted for the largest market
share. This is due to the region's advanced healthcare
infrastructure, high prevalence of chronic diseases, and increasing
adoption of advanced drug delivery systems. Strong regulatory
support, high patient awareness, and significant investments in
R&D by pharmaceutical companies also contribute to North America's dominant position. Meanwhile,
the Asia-Pacific region is
expected to experience the highest CAGR, driven by rising
healthcare expenditure, growing awareness of advanced medical
technologies, and an expanding biopharmaceutical industry.
For more information, Inquire Now
Related Reports:
Injectable Drug Delivery Market
Fill Finish Manufacturing Market
Pharmaceutical Excipients Market
Topical Drug Delivery Market
Pharmaceutical Drug Delivery Market
Get access to the latest updates on Prefilled Syringes
Companies and Prefilled Syringes Market Share
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.com/news-releases/prefilled-syringes-market-worth-13-1-billion-by-2030-driven-by-rising-chronic-illness-rates--marketsandmarkets-302208416.html
SOURCE MarketsandMarkets